These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2111110)

  • 1. The prevalence of hepatitis C virus antibodies among hemodialysis patients.
    Zeldis JB; Depner TA; Kuramoto IK; Gish RG; Holland PV
    Ann Intern Med; 1990 Jun; 112(12):958-60. PubMed ID: 2111110
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center.
    Selgas R; Martinez-Zapico R; Bajo MA; Romero JR; Munoz J; Rinon C; Miranda B; Miguel JL
    Perit Dial Int; 1992; 12(1):28-30. PubMed ID: 1311962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels.
    Rumi MG; Colombo M; Gringeri A; Mannucci PM
    Ann Intern Med; 1990 Mar; 112(5):379-80. PubMed ID: 2106281
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers.
    Everhart JE; Di Bisceglie AM; Murray LM; Alter HJ; Melpolder JJ; Kuo G; Hoofnagle JH
    Ann Intern Med; 1990 Apr; 112(7):544-5. PubMed ID: 1690526
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of anti-HCV in patients on long-term hemodialysis.
    Oguchi H; Terashima M; Tokunaga S; Kiyosawa K; Tanaka E; Furuta S; Kanno Y; Aizawa T; Nishioka K
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):313-7. PubMed ID: 2113144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis G virus infection in Slovenian hemodialysis patients as determined by the detection of viral genome and E2 antibodies.
    Seme K; Poljak M; Jeverica S; Koren A; Sasa Zuzek-Resek S
    Nephron; 1998 Aug; 79(4):426-9. PubMed ID: 9689158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence of anti-HCV and ALT in blood donors].
    Martín Y; Marzo L; Cinto F; Delgado P; Buñuel C
    Sangre (Barc); 1990 Jun; 35(3):197-200. PubMed ID: 2118686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays.
    Chan TM; Lok AS; Cheng IK; Chan RT
    Hepatology; 1993 Jan; 17(1):5-8. PubMed ID: 7678575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors.
    Dentico P; Buongiorno R; Volpe A; Carlone A; Carbone M; Manno C; Proscia F; Pastore G; Schiraldi O
    Clin Nephrol; 1992 Jul; 38(1):49-52. PubMed ID: 1499169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of hepatitis B, hepatitis C and GBV-C in ANCA-positive hemodialysis patients.
    Kallinowski B; Seipp S; Fatehi S; Sommerfeld U; Andrassy K; Stremmel W; Theilmann L
    Nephron; 1997; 77(3):357-8. PubMed ID: 9375833
    [No Abstract]   [Full Text] [Related]  

  • 12. GB virus C and hepatitis C virus infections in hemodialysis patients in eight Japanese centers.
    Watanabe T; Ishiguro M; Kametani M; Sugai Y; Takakuwa K; Akahane Y; Masuko K; Shimizu M; Kojima M; Fujita K; Tsuda F; Okamoto H
    Nephron; 1997; 76(2):171-5. PubMed ID: 9200408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-HCV antibodies among blood donors in Cantabria. Incidence and relation to transaminase levels].
    Pastor JM; Hermosa V; Ruiz Tagle MA; Zubizarreta A
    Sangre (Barc); 1990 Jun; 35(3):205-7. PubMed ID: 2118687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alanine aminotransferase screening and hepatitis C virus antibody.
    Burckhardt JJ; Friedli H; Gardi A; Heiniger HJ
    Lancet; 1990 Aug; 336(8712):447-8. PubMed ID: 1974981
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevalence of viral hepatitis G infection in hemodialysis patients and coinfection with viral hepatitis B and C].
    Klusonová H; Plísková L; Palicka V; Fixa P
    Vnitr Lek; 2001 Oct; 47(10):678-81. PubMed ID: 11789005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populations.
    Nübling CM; Bialleck H; Fürsch AJ; Scharrer I; Schramm W; Seifried E; Schmidt U; Staszewski S; Löwer J
    J Med Virol; 1997 Nov; 53(3):218-24. PubMed ID: 9365885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further insights into hepatitis C.
    Colombo M
    Ital J Gastroenterol; 1991 Dec; 23(9):574-5. PubMed ID: 1662092
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus.
    Bruno S; Rossi S; Petroni ML; Villa E; Zuin M; Podda M
    BMJ; 1994 Mar; 308(6930):697. PubMed ID: 8142795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.